Quote (Saucisson6000 @ Apr 11 2020 09:10pm)
It's not even associated with azithromycine in your paper?
Wtf LOL
hyrdoxy
azithro + hydroxy
azithro + hydroxy + zinc
all being done simultaneously, as randomized control as they should be.
not cherry picked data and intentionally dropping hundreds of patients (France study)
Quote (Black XistenZ @ Apr 11 2020 08:54pm)
Honestly, with a multitude of known demographic and clinical risk factors (age, obesity, smoking, asthma, gender?, variations in the health condition in which patients were admitted), I feel like a sample size of ~30 people in each subgroup is really stretching it in terms of having representative and comparable samples.
It is one study, and it is clearly pointing toward hydroxychloroquine having no, or even and adverse, effect on Covid-19 patients - but we shouldnt get ahead of ourselves and dismiss hydroxychloroquine outright. A single, small sample size study is an indication, not a definitive proof. Due to this study, the hopes of having found a drug against Covid-19 must take a big hit, but the study's meaningfulness shouldnt be overstated either.
tldr: interesting first data, but to reach a proper conclusion, we need more data/studies.
all these studies will be underpowered atm
you're not gonna get an ideal sample with how chaotic these hospitals are. Detroit is honestly a shit show. it's been going on in NY and WA for much longer as well. any institution could have come up with data by now but everyone is lagging due to the sheer chaos